Published 22 October 2026
Most people don’t avoid difficult conversations because they lack...
Tuesday, 10 Nov 2026
Author(s): Alex Palumbo
Medical affairs (MA) serves as a bridge across various business units in a company and plays a crucial role to improve patient’s outcome by engaging with external stakeholders. In contrast to other business units, such as sales, the measurement of the impact of MA and their field medical (FM) personnel such as the medical science liaisons (MSLs) is still highly debated in the community as key performance indicators (KPIs) such as activity metrics are mostly adapted from commercial performance measurements that might not adequately represent the impact of MA. Although recent literature (see below) suggests a much more holistic approach to measure the impact of FM and their MSLs, this article focuses on the conundrum of how the industry is split in considering activity metrics and why it is sensible to maintain it.
As shown by a report from 2023 “Measuring the Impact of Medical Affairs”1,a survey of FM leaders elucidated a disparity between the priority of key outcome metrics that FM leaders considered important and what their team was measuring. The results show that activity metrics was the main measured KPI (35%) although FM leaders considered this KPI as one of the least relevant (6%). Moreover, the report suggests a “medical impact model” whose foundation is based on operational effectiveness to fulfill other metrics that are more HCP and patient centered. Operational effectiveness might be viewed as either to be aligned to activity metrics such as frequent contacts to ensure a certain level of impact on HCP and patients or not to be affected by frequent visits due to lack of knowledge about the exchange; a further recent report from 2024 named “Field medical impact measurement: A biopharma consensus”2 aimed to create novel Field Medical Impact Indicators (FMIIs) to assess the impact and value of FM roles. The report states that activity metrics such as frequency of contact with HCPs do not necessarily parallel the impact or even value created by MSLs (definitions of “impact” and “value” can be found in the report). Thus, MA and their MSLs need to consider other objectives of their role and functions to fulfill expectations of HCPs, patients, and even their own company.
Tuesday, 10 Nov 2026
Friday, 6 Nov 2026
Thursday, 5 Nov 2026
| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
Reading this content is completely free
Already have an account? Sign in